Found 99 matching trials
Post Marketing Surveillance: Newly Diagnosed Glioblastoma Multiforme Treated With Radiotherapy/Temozolomide and Adjuvant Temozolomide (Study P04739) N/A The purpose of this surveillance is to collect more safety and efficacy dat...
Show More Location
Multiple Locations
Learn More & Join Trial
Radiation Boost for Newly Diagnosed Glioblastoma Multiforme PHASE1 The purpose of this study is to determine treatment related toxicity, tumor...
Show More Location
Methodist University Hospital
Learn More & Join Trial
Dendritic Cell-Based Tumor Vaccine Adjuvant Immunotherapy of Human Glioblastoma Multiforme (WHO Grade IV Gliomas) PHASE2 Purposes:
The purpose of this phase-II clinical trial is to determine whet...
Show More Location
China Medical University Hospital
Learn More & Join Trial
A Dose Finding Study of [177Lu]Lu-DOTA-TATE in Newly Diagnosed Glioblastoma in Combination With Standard of Care and in Recurrent Glioblastoma as a Single Agent. PHASE1 A Dose Finding Study of \[177Lu\]Lu-DOTA-TATE in Newly Diagnosed Glioblasto...
Show More Status
Active Not Recruiting
Location
Col Uni Med Center New York Presby
Learn More & Join Trial
A Phase 2 Trial of High-Dose Ascorbate in Glioblastoma Multiforme PHASE2 This clinical trial evaluates adding high-dose ascorbate (vitamin C) to sta...
Show More Status
Active Not Recruiting
Location
Holden Comprehensive Cancer Center
Learn More & Join Trial
Efficacy and Safety Study of Lomustine/Temozolomide Combination Therapy vs. Standard Therapy for Glioblastoma Patients PHASE3 The prognosis of patients with newly diagnosed glioblastoma is dismal despi...
Show More Location
Depatment of Neurosurgery, Charité, University Hospital Berlin
Learn More & Join Trial
Image-derived Prediction of Response to Chemo-radiation in Glioblastoma N/A This study seeks to investigate if advanced image-analysis of diagnostic sc...
Show More Location
Department of Oncology, Section for Radiotherapy, Rigshospitalet
Learn More & Join Trial
Glasdegib (PF-04449913) With Temozolomide Newly Diagnosed Glioblastoma PHASE1 Glioblastomas (GBMs) are the most common malignant primary brain tumors. De...
Show More Location
Institut Catalá de Oncología Badalona/Hospital Germans Trias i Pujol
Learn More & Join Trial
Whole Brain Radiotherapy With or Without Temozolomide at Daily Fixed-dose for Brain Metastases Treatment PHASE2 RATIONALE
* Fractionated radiotherapy uses high-energy photons to kill, or...
Show More Location
Instituto Nacional de Cancerología de México
Learn More & Join Trial
Innovative SonoCloud-9 Device for Blood Brain Barrier Opening in First Line Temozolomide Glioblastoma Patients. PHASE2 Glioblastoma (GBM) is an aggressive cancer with a progression-free survival...
Show More Location
Katholieke Universiteit Leuven
Learn More & Join Trial